Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Indore Pharma Summit 2026 | 8th May 2026 | Indore Marriott Hotel The post Prof ...
Indore Pharma Summit 2026 | 8th May 2026 | Indore Marriott Hotel The post Indor...
Indore Pharma Summit 2026 | 8th May 2026 | Indore Marriott Hotel The post Mr Ga...
From AI and smart manufacturing to sustainability,quality culture,faster drug d...
Company representatives to participate in discussions on AI, clinical trials, ...
The collaboration follows a successful pilot phase, where XtalPi’s integrated qu...
Approval expands indication for Trastuzumab Deruxtecan in combination with Pert...
Launch follows European Commission authorisation and expands availability of c...
Knowledge paper outlines growth drivers, biosimilars opportunity and priorities...
Company becomes sole first applicant for generic Larotrectinib Capsules with P...
Company to transition ursodeoxycholic acid production from Italy to India by e...
EMA has now begun reviewing its use in adults following a non-cardioembolic isch...
Upon completion of the transaction, Ignite will separate from Aditxt and is expe...
The programme will investigate the ways in which AI can enhance the evaluation o...
Partnership focuses on clinical capability building, patient support, technolo...
Saloni Paliwal, Co-founder, Voy India highlights the evolution of GLP-1 therapi...
